ロード中...

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease

The main treatments for patients with nonalcoholic fatty liver disease (NAFLD) are currently based on lifestyle changes, including ponderal decrease and dietary management. However, a subgroup of patients with nonalcoholic steatohepatitis (NASH), who are unable to modify their lifestyle successfully...

詳細記述

保存先:
書誌詳細
出版年:Pharmaceuticals (Basel)
主要な著者: Abenavoli, Ludovico, Falalyeyeva, Tetyana, Boccuto, Luigi, Tsyryuk, Olena, Kobyliak, Nazarii
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6315965/
https://ncbi.nlm.nih.gov/pubmed/30314377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11040104
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!